Free Trial

Beauty Health (SKIN) Stock Forecast & Price Target

Beauty Health logo
$1.53 -0.26 (-14.53%)
(As of 11/15/2024 ET)

Beauty Health - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Sell
1
Hold
3
Buy
1

Based on 5 Wall Street analysts who have issued ratings for Beauty Health in the last 12 months, the stock has a consensus rating of "Hold." Out of the 5 analysts, 1 has given a sell rating, 3 have given a hold rating, and 1 has given a buy rating for SKIN.

Consensus Price Target

$2.55
66.67% Upside
According to the 5 analysts' twelve-month price targets for Beauty Health, the average price target is $2.55. The highest price target for SKIN is $5.00, while the lowest price target for SKIN is $1.00. The average price target represents a forecasted upside of 66.67% from the current price of $1.53.
Get the Latest News and Ratings for SKIN and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Beauty Health and its competitors.

Sign Up

SKIN Analyst Ratings Over Time

TypeCurrent Forecast
11/18/23 to 11/17/24
1 Month Ago
10/19/23 to 10/18/24
3 Months Ago
8/20/23 to 8/19/24
1 Year Ago
11/18/22 to 11/18/23
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
1 Buy rating(s)
1 Buy rating(s)
2 Buy rating(s)
4 Buy rating(s)
Hold
3 Hold rating(s)
7 Hold rating(s)
7 Hold rating(s)
8 Hold rating(s)
Sell
1 Sell rating(s)
3 Sell rating(s)
3 Sell rating(s)
3 Sell rating(s)
Consensus Price Target$2.55$2.46$5.39$9.56
Forecasted Upside66.67% Upside53.65% Upside250.19% Upside322.81% Upside
Consensus Rating
Hold
Reduce
Reduce
Hold

SKIN Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

SKIN Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Beauty Health Stock vs. The Competition

TypeBeauty HealthMedical CompaniesS&P 500
Consensus Rating Score
2.00
2.80
2.50
Consensus RatingHoldModerate BuyModerate Buy
Predicted Upside66.67% Upside28,534.42% Upside9.87% Upside
News Sentiment Rating
Positive News

See Recent SKIN News
Positive News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
11/13/2024Canaccord Genuity Group
1 of 5 stars
 Boost TargetHold ➝ Hold$1.25 ➝ $1.75-2.78%
8/9/2024Piper Sandler
2 of 5 stars
 Reiterated RatingUnderweight ➝ Underweight$1.50 ➝ $1.00-17.01%
7/26/2024Stifel Nicolaus
4 of 5 stars
 Lower TargetHold ➝ Hold$4.00 ➝ $2.00+11.11%
5/13/2024DA Davidson
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingBuy ➝ Buy$5.00 ➝ $5.00+82.82%
5/13/2024TD Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetHold ➝ Hold$4.00 ➝ $3.00+9.09%
11/15/2023Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeBuy ➝ Hold
11/14/2023JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeNeutral ➝ Underweight
11/14/2023Benchmark
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeBuy ➝ Hold
11/14/2023Raymond James
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeMarket Perform ➝ Underperform
11/14/2023William Blair
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeOutperform ➝ Market Perform
9/19/2023Imperial Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageOutperform
3/20/2023BNP Paribas
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeUnderperform ➝ Neutral
2/16/2023Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetOutperform$20.00 ➝ $15.00+12.78%
11/23/2022The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetBuy$22.00 ➝ $19.00+89.62%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Sunday at 07:19 AM ET.


SKIN Forecast - Frequently Asked Questions

According to the research reports of 5 Wall Street equities research analysts, the average twelve-month stock price forecast for Beauty Health is $2.55, with a high forecast of $5.00 and a low forecast of $1.00.

5 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Beauty Health in the last year. There is currently 1 sell rating, 3 hold ratings and 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "hold" SKIN shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in SKIN, but not buy additional shares or sell existing shares.

According to analysts, Beauty Health's stock has a predicted upside of 66.67% based on their 12-month stock forecasts.

Beauty Health has been rated by research analysts at Canaccord Genuity Group in the past 90 days.

Analysts like Beauty Health less than other "medical" companies. The consensus rating for Beauty Health is Hold while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how SKIN compares to other companies.


This page (NASDAQ:SKIN) was last updated on 11/17/2024 by MarketBeat.com Staff
From Our Partners